Pfizer Stock Falls 8% in a Month: Should You Buy the Dip?

Pfizer's (PFE) stock has declined 7.8% in the past month. Though the stock has been affected by declining sales of its COVID products, a lot of this stock price decline could be due to the broader drug/biotech sector's decline in the past month. Lower-than-expected sales of Lilly (LLY) and Novo Nordisk's (NVO) popular diabetes and obesity drugs in the third quarter, guidance cuts, pipeline setbacks and the appointment of Robert F. Kennedy Jr., a vaccine skeptic, as head of Health and Human Services (HHS) ha ...